Randomized phase II study of two schedules of flavopiridol given as timed sequential therapy with cytosine arabinoside and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia (Q36366636)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized phase II study of two schedules of flavopiridol given as timed sequential therapy with cytosine arabinoside and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia |
scientific article |
Statements
1 reference
Randomized phase II study of two schedules of flavopiridol given as timed sequential therapy with cytosine arabinoside and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia (English)
1 reference
Megan Othus
1 reference
Elihu H Estey
1 reference
Judith E Karp
1 reference
Elizabeth Garrett-Mayer
1 reference
Michelle A Rudek
1 reference
B Douglas Smith
1 reference
Jacqueline M Greer
1 reference
D Michelle Drye
1 reference
Karen Mackey
1 reference
Kathleen Shannon Dorcy
1 reference
Steven D Gore
1 reference
Mark J Levis
1 reference
Michael A McDevitt
1 reference
Hetty E Carraway
1 reference
Keith W Pratz
1 reference
Douglas E Gladstone
1 reference
Margaret M Showel
1 reference
L Austin Doyle
1 reference
John J Wright
1 reference
John M Pagel
1 reference
1 reference
1 reference
Identifiers
1 reference